The GLP-1R Agonist Exendin-4 Attenuates Hyperglycemia-Induced Chemoresistance in Human Endometrial Cancer Cells Through ROS-Mediated Mitochondrial Pathway

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway

(2020) Huan He et al.   Frontiers in Pharmacology

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma

(2020) Danfeng Xue et al.   Oxidative Medicine and Cellular Longevity

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

(2019) Milana Bergamino et al.   BMC CANCER

Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

(2019) Afsana Afroz et al.   BMC HEALTH SERVICES RESEARCH

β‑elemene enhances cisplatin‑induced apoptosis in bladder cancer cells through the ROS‑AMPK signaling pathway

(2019) Daoju Gan et al.   Oncology Letters

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer

(2018) Ranka Kanda et al.   BMC CANCER

Altered mitochondrial function in insulin-deficient and insulin-resistant states

(2018) Gregory N. Ruegsegger et al.   JOURNAL OF CLINICAL INVESTIGATION

Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells

(2018) Loredana Bergandi et al.   Frontiers in Pharmacology

Reactive oxygen species and cancer paradox: To promote or to suppress?

(2017) Sehamuddin Galadari et al.   FREE RADICAL BIOLOGY AND MEDICINE

International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013

(2017) Joannie Lortet-Tieulent et al.   JNCI-Journal of the National Cancer Institute

International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013

(2017) Joannie Lortet-Tieulent et al.   JNCI-Journal of the National Cancer Institute

Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model

(2017) Mona M. Allam et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway

(2017) A Vasconcelos-dos-Santos et al.   Oncogenesis

Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

(2016) Jose J.G. Marin et al.   BLOOD REVIEWS

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

(2016) Alessandro Ottaiano et al.   ONCOLOGY

Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants

(2016) Aysegul Cort et al.   Oxidative Medicine and Cellular Longevity

Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia

(2016) Belete Biadgo et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

(2015) Khalid O Alfarouk et al.   Cancer Cell International

Review paper Angiomodulatory properties of Rhodiola spp. and other natural antioxidants

(2015) Dorota M. Radomska-Leśniewska et al.   Central European Journal of Immunology

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target

(2015) Ryoichi Asaka et al.   LABORATORY INVESTIGATION

Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice

(2015) YU ZHANG et al.   ONCOLOGY REPORTS

Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth

(2014) Takashi Nomiyama et al.   DIABETES

High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity

(2014) Alessia Garufi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Hyperglycemia, a Neglected Factor during Cancer Progression

(2014) Wanxing Duan et al.   Biomed Research International

Validation of Reference Genes for Normalization Gene Expression in Reverse Transcription Quantitative PCR in Human Normal Thyroid and Goiter Tissue

(2014) Raquel Weber et al.   Biomed Research International

HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

(2012) Sophie Doublier et al.   BMC CANCER

The Links Between Insulin Resistance, Diabetes, and Cancer

(2012) Etan Orgel et al.   Current Diabetes Reports

Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms

(2012) Biagio Arcidiacono et al.   Experimental Diabetes Research

Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803

(2012) Jeffrey A. Meyerhardt et al.   JNCI-Journal of the National Cancer Institute

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression

(2009) C Riganti et al.   BRITISH JOURNAL OF PHARMACOLOGY

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

(2009) Bei B. Zhang et al.   Cell Metabolism

Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1 

(2008) C. Riganti et al.   EUROPEAN RESPIRATORY JOURNAL

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus

(2008) Bethany B. Barone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION